bgcolor="#ffffff" align="center" colspan="2" | Furosemide |
align="center" colspan="2" | 4-chloro-N-furfuryl- 5-sulfamoylanthranilic acid |
CAS number 54-31-9 | ATC code C03CA01 |
| bgcolor="#eeeeee" | Chemical formula | bgcolor="#ddeeff" | CHClNOS |
| bgcolor="#eeeeee" | Molecular weight | bgcolor="#ddeeff" | 330.747 |
| bgcolor="#eeeeee" | Bioavailability | bgcolor="#ddeeff" | 43-69% |
| bgcolor="#eeeeee" | Metabolism | bgcolor="#ddeeff" | hepatic |
| bgcolor="#eeeeee" | Elimination half-life | bgcolor="#ddeeff" | up to 100 minutes |
| bgcolor="#eeeeee" | Excretion | bgcolor="#ddeeff" | renal 66%, biliary 33% |
| bgcolor="#eeeeee" | Pregnancy category | bgcolor="#ddeeff" | C (Australia) |
| bgcolor="#eeeeee" | Legal status | bgcolor="#ddeeff" | Schedule 4 (Aust) POM (UK) |
| bgcolor="#eeeeee" | Routes of administration | bgcolor="#ddeeff" | oral, IV, IM |